Genmab — April 2017
-
ok - tak
-
God morgen.

-
Mødet var lidt et non-event, markedet var bange for at Trump ville spille hårdt overfor Kina og at det ville blive en gentagelse af mødet med Merkel. Nu taler alle om Syrien, og ikke at President Trump har en anden holdning til Kina end Presidential Candidate Trump.
-
al europæisk biotek ser ud til at blive trykket indtil videre i dag
-
gad vide, om vi kan få flere dårlige nyheder inden ugen er omme? -13,5% ned på en uge, så kan man mærke, at det er biotek...
-
1240 er stadig et stærkt gulv.

-
This study into Refractory Natural Killer/T-Cell Lymphoma, Nasal Type, now recruiting in Asia https://clinicaltrials.gov/ct2/show/NCT02927925?term=daratumumab+OR+ofatumumab&lup_s=04%2F06%2F2017&rank=1
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind